BX vs CNS
Head-to-Head Stock Analysis & Investment Rating
Last Updated: Nov 11, 2026
BX
CNS
Investment Advisor Scores
CNS
AI Analyst Insights
Detailed Metrics Comparison
| Metric | BX | CNS | Winner |
|---|---|---|---|
|
Valuation
Lower P/E and PEG ratios suggest a stock may be undervalued relative to earnings and growth. Value investors prefer lower multiples. |
|||
| Forward P/E | 16.7785 | 18.5874 | BX |
| PEG Ratio | 1.2244 | 1.3563 | BX |
|
Growth
Higher revenue and earnings growth rates indicate a company is expanding faster. Strong growth often justifies premium valuations. |
|||
| Revenue Growth | -0.5% | 11.1% | CNS |
| Earnings Growth | 3.7% | 0.0% | BX |
|
Quality & Profitability
Higher Tradestie Score and profit margins reveal how efficiently a company operates. Strong profitability indicates competitive advantages. |
|||
| Tradestie Score | 40.6/100 | 43.0/100 | CNS |
| Profit Margin | 23.0% | 28.2% | CNS |
|
Risk Profile
Lower Beta and Implied Volatility values indicate reduced market risk. Conservative investors favor stocks with less price volatility. |
|||
| Beta | 1.00 | 1.00 | Tie |
|
Sentiment
AI Recommendation reflects overall analyst and proprietary sentiment. Stronger recommendations signal higher conviction. |
|||
| AI Recommendation | HOLD | HOLD | Tie |
Relative Price Performance (Last 90 Days)
Current Technical Phase
BX
NeutralMixed signals - no dominant trend phase, RSI 55
CNS
DistributionPrice near a flattening SMA50 (slope -5.6%) with fading momentum, RSI 50
Fundamentals Snapshot
| Metric | BX | CNS |
|---|---|---|
| Market Cap | — | — |
| Forward P/E | 16.5 | 19.6 |
| Trailing P/E | 27.3 | 22.7 |
| Revenue (TTM) | — | — |
| Revenue Growth | 0.0% | 0.1% |
| Gross Margin | 1.0% | 0.5% |
| Operating Margin | 0.5% | 0.3% |
| EPS | 4.49 | 3.25 |
| Dividend Yield | 0.04% | 0.04% |